Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Hair loss is common in IBD patients, and some medications may lower the risk.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

New therapies for rare skin diseases show promise but need more research.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

TNF-alpha inhibitors can cause various immune-related skin issues.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Some drugs used to treat inflammation may cause hair loss.

New treatments for hair loss show promise with advanced therapies and better targeting.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Atorvastatin in a keratin hydrogel may help treat skin scars effectively.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.